Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Preventing the onset of major depression based on the level and profile of risk of primary care attendees: Protocol of a cluster randomised trial (the predictD-CCRT study)

  • Bellón, J.A.
  • Conejo-Cerón, S.
  • Moreno-Peral, P.
  • King, M.
  • Nazareth, I.
  • Martín-Pérez, C.
  • Fernández-Alonso, C.
  • Ballesta-Rodríguez, M.I.
  • Fernández, A.
  • Aiarzaguena, J.M.
  • Montón-Franco, C.
  • Ibanez-Casas, I.
  • Rodríguez-Sánchez, E.
  • Rodríguez-Bayón, A.
  • Serrano-Blanco, A.
  • Gómez, M. C.
  • LaFuente, P.
  • Muñoz García, M.M.
  • Mínguez-Gonzalo, P.
  • Araujo, L.
  • Palao, D.
  • Espinosa-Cifuentes, M.
  • Zubiaga, F.
  • Navas-Campaña, D.
  • Mendive, J.
  • Aranda-Regules, J.
  • Rodriguez-Morejón, A.
  • Salvador-Carulla, L.
  • de Dios Luna, J.
Background: The ''predictD algorithm'' provides an estimate of the level and profile of risk of the onset of major depression in primary care attendees. This gives us the opportunity to develop interventions to prevent depression in a personalized way. We aim to evaluate the effectiveness, cost-effectiveness and cost-utility of a new intervention, personalized and implemented by family physicians (FPs), to prevent the onset of episodes of major depression.Methods/Design: This is a multicenter randomized controlled trial (RCT), with cluster assignment by health center and two parallel arms. Two interventions will be applied by FPs, usual care versus the new intervention predictD-CCRT. The latter has four components: a training workshop for FPs; communicating the level and profile of risk of depression; building up a tailored bio-psycho-family-social intervention by FPs to prevent depression; offering a booklet to prevent depression; and activating and empowering patients. We will recruit a systematic random sample of 3286 non-depressed adult patients (1643 in each trial arm), nested in 140 FPs and 70 health centers from 7 Spanish cities. All patients will be evaluated at baseline, 6, 12 and 18 months. The level and profile of risk of depression will be communicated to patients by the FPs in the intervention practices at baseline, 6 and 12 months. Our primary outcome will be the cumulative incidence of major depression (measured by CIDI each 6 months) over 18 months of follow-up. Secondary outcomes will be health-related quality of life (SF-12 and EuroQol), and measurements of cost-effectiveness and cost-utility. The inferences will be made at patient level. We shall undertake an intention-to-treat effectiveness analysis and will handle missing data using multiple imputations. We will perform multi-level logistic regressions and will adjust for the probability of the onset of major depression at 12 months measured at baseline as well as for unbalanced variables if appropriate. The economic evaluation will be approached from two perspectives, societal and health system.Discussion: To our knowledge, this will be the first RCT of universal primary prevention for depression in adults and the first to test a personalized intervention implemented by FPs. We discuss possible biases as well as other limitations.Trial registration: ClinicalTrials.gov identifier: NCT01151982.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

A personalized intervention to prevent depression in primary care: cost-effectiveness study nested into a clustered randomized trial

  • Fernandez, A.
  • Mendive, J.M.
  • Conejo-Ceron, S.
  • Moreno-Peral, P.
  • King, M.
  • Nazareth, I.
  • Martin-Perez, C.
  • Fernandez-Alonso, C.
  • Rodriguez-Bayon, A.
  • Aiarzaguena, J.M.
  • Monton-Franco, C.
  • Serrano-Blanco, A.
  • Ibanez-Casas, I.
  • Rodriguez-Sanchez, E.
  • Salvador-Carulla, L.
  • Garay, P.B.
  • Ballesta-Rodriguez, M.I.
  • LaFuente, P.
  • Munoz-Garcia, M.D.
  • Minguez-Gonzalo, P.
  • Araujo, L.
  • Palao, D.
  • Gomez, M.C.
  • Zubiaga, F.
  • Navas-Campana, D.
  • Aranda-Regules, J.M.
  • Rodriguez-Morejon, A.
  • Luna, J.D.
  • Bellon, J.A.
Background: Depression is viewed as a major and increasing public health issue, as it causes high distress in the people experiencing it and considerable financial costs to society. Efforts are being made to reduce this burden by preventing depression. A critical component of this strategy is the ability to assess the individual level and profile of risk for the development of major depression. This paper presents the cost-effectiveness of a personalized intervention based on the risk of developing depression carried out in primary care, compared with usual care. Methods: Cost-effectiveness analyses are nested within a multicentre, clustered, randomized controlled trial of a personalized intervention to prevent depression. The study was carried out in 70 primary care centres from seven cities in Spain. Two general practitioners (GPs) were randomly sampled from those prepared to participate in each centre (i.e. 140 GPs), and 3326 participants consented and were eligible to participate. The intervention included the GP communicating to the patient his/her individual risk for depression and personal risk factors and the construction by both GPs and patients of a psychosocial programme tailored to prevent depression. In addition, GPs carried out measures to activate and empower the patients, who also received a leaflet about preventing depression. GPs were trained in a 10- to 15-h workshop. Costs were measured from a societal and National Health care perspective. Qualityadjustedlife years were assessed using the EuroQOL five dimensions questionnaire. The time horizon was 18 months. Results: With a willingness-to-pay threshold of (sic)10, 000 ((sic)8568) the probability of cost-effectiveness oscillated from 83% (societal perspective) to 89% (health perspective). If the threshold was increased to (sic)30, 000 ((sic)25, 704), the probability of being considered cost-effective was 94% (societal perspective) and 96%, respectively (health perspective). The sensitivity analysis confirmed these results. Conclusions: Compared with usual care, an intervention based on personal predictors of risk of depression implemented by GPs is a cost-effective strategy to prevent depression. This type of personalized intervention in primary care should be further developed and evaluated.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Body mass index interacts with a genetic-risk score for depression increasing the risk of the disease in high-susceptibility individuals

  • Anguita-Ruiz, Augusto
  • Zarza-Rebollo, Juan Antonio
  • Pérez-Gutiérrez, Ana M.
  • Molina, Esther
  • Gutiérrez, Blanca
  • Bellón, Juan Ángel
  • Moreno-Peral, Patricia
  • Conejo-Cerón, Sonia
  • Aiarzagüena, Jose María
  • Ballesta-Rodríguez, M. Isabel
  • Fernández, Anna
  • Fernández-Alonso, Carmen
  • Martín-Pérez, Carlos
  • Montón-Franco, Carmen
  • Rodríguez-Bayón, Antonina
  • Torres-Martos, Álvaro
  • López-Isac, Elena
  • Cervilla, Jorge
  • Rivera, Margarita
Depression is strongly associated with obesity among other chronic physical diseases. The latest mega- and meta-analysis of genome-wide association studies have identified multiple risk loci robustly associated with depression. In this study, we aimed to investigate whether a genetic-risk score (GRS) combining multiple depression risk single nucleotide polymorphisms (SNPs) might have utility in the prediction of this disorder in individuals with obesity. A total of 30 depression-associated SNPs were included in a GRS to predict the risk of depression in a large case-control sample from the Spanish PredictD-CCRT study, a national multicentre, randomized controlled trial, which included 104 cases of depression and 1546 controls. An unweighted GRS was calculated as a summation of the number of risk alleles for depression and incorporated into several logistic regression models with depression status as the main outcome. Constructed models were trained and evaluated in the whole recruited sample. Non-genetic-risk factors were combined with the GRS in several ways across the five predictive models in order to improve predictive ability. An enrichment functional analysis was finally conducted with the aim of providing a general understanding of the biological pathways mapped by analyzed SNPs. We found that an unweighted GRS based on 30 risk loci was significantly associated with a higher risk of depression. Although the GRS itself explained a small amount of variance of depression, we found a significant improvement in the prediction of depression after including some non-genetic-risk factors into the models. The highest predictive ability for depression was achieved when the model included an interaction term between the GRS and the body mass index (BMI), apart from the inclusion of classical demographic information as marginal terms (AUC = 0.71, 95% CI = [0.65, 0.76]). Functional analyses on the 30 SNPs composing the GRS revealed an over-representation of the mapped genes in signaling pathways involved in processes such as extracellular remodeling, proinflammatory regulatory mechanisms, and circadian rhythm alterations. Although the GRS on its own explained a small amount of variance of depression, a significant novel feature of this study is that including non-genetic-risk factors such as BMI together with a GRS came close to the conventional threshold for clinical utility used in ROC analysis and improves the prediction of depression. In this study, the highest predictive ability was achieved by the model combining the GRS and the BMI under an interaction term. Particularly, BMI was identified as a trigger-like risk factor for depression acting in a concerted way with the GRS component. This is an interesting finding since it suggests the existence of a risk overlap between both diseases, and the need for individual depression genetics-risk evaluation in subjects with obesity. This research has therefore potential clinical implications and set the basis for future research directions in exploring the link between depression and obesity-associated disorders. While it is likely that future genome-wide studies with large samples will detect novel genetic variants associated with depression, it seems clear that a combination of genetics and non-genetic information (such is the case of obesity status and other depression comorbidities) will still be needed for the optimization prediction of depression in high-susceptibility individuals.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Use of a personalised depression intervention in primary care to prevent anxiety: a secondary study of a cluster randomised trial

  • Moreno-Peral, P
  • Conejo-Ceron, S
  • Luna, JD
  • King, M
  • Nazareth, I
  • Martin-Perez, C
  • Fernandez-Alonso, C
  • Ballesta-Rodriguez, MI
  • Fernandez, A
  • Aiarzaguena, JM
  • Monton-Franco, C
  • Bellon, JA
Background In the predictD-intervention. GPs used a personalised biopsychosocial programme to prevent depression. This reduced the incidence of major depression by 21.0%. although the results were not statistically significant. Aim To determine whether the predictD-intervention is effective at preventing anxiety in primary cam patients without depression or anxiety. Design and setting Secondary study of a cluster randomised trial with practices randomly assigned to either the predictD-intervention or usual care. This study was conducted in seven Spanish cities from October 2010 to July 2012. Method In each city, 10 practices and two GPs per practice, as well as four to six patients every recruiting day, were randomly selected until there were 26-27 eligible patients for each GP The endpoint was cumulative incidence of anxiety as measured by the PRIME-MD screening tool over 18 months. Results A total of 3326 patients without depression and 140 GPs from 70 practices consented and were eligible to participate; 328 of these patients were removed because they had an anxiety syndrome at baseline. Of the 2998 valid patients. 2597 (86.6%) were evaluated at the end of the study. At 18 months. lac.% (95% CI = 8.7% to 12.1%) of the patients in the predictD-intervention group developed anxiety compared with 13.1% (95% CI =11.4% to 14.8%) in the usual-care group (absolute difference = -2.7%195% CI = -5.1% to -0.3%1; P=0.029). Conclusion A personalised intervention delivered by the prevention of depression prrmded a ; but statistically significant reduction in the incidence of anxiety